http://capitalwatchpa.com/node/6935 In a rare moment,

New Post Public Reply Private Reply Replies (0) Message Board
newjack
http://capitalwatchpa.com/node/6935

In a rare moment, political analysts Tony May and Charlie Gerow actually agree on this month's topic. Read their opinions below. By the way, the two can be seen on Sundays at 11:30 a.m. on Channel 21's "Face the State."

YES

By Charlie Gerow

It's hard to imagine agreeing with Sen. Daylin Leach. So, I'll have to re-think my position. But in the meantime I will stick with my instinct and ask: why not legalize medical marijuana? In the absence of compelling reasons not to, I will part with some of my conservative brethren.

I suffer with glaucoma. I've already lost a frightening percentage of my eyesight. My condition is currently controlled with daily dosages of eye drops. If that should fail, I sure as heck would want every known therapy available to me, including marijuana.

Of course there are many illnesses much more debilitating than glaucoma that can be treated with marijuana, from Alzheimer's to fibromyalgia to HIV/AIDS to cancer. Many people with conditions far worse than mine are asking for the right to use marijuana legally.

So are many in the medical community. Years ago, a National Institutes of Health panel concluded that smoking marijuana could help treat a number of chronic conditions including pain and nausea. It could also help people who failed to respond to other remedies the study said.

In one survey more than 70 percent of U.S. cancer specialists said they would prescribe marijuana if it were legal. Nearly half of those interviewed said they had already recommended that their patients break the law to use marijuana.

Sanjay Gupta, CNN's medical guru and a well-renowned neurosurgeon, once spoke out against legalization of marijuana for medical purposes. But this summer he wrote a piece entitled "Why I changed my mind on weed," in which he apologized for his earlier stand. His further research, he said, had convinced him that he was simply wrong. He discussed the anti-cancer effects of marijuana and cited another study in which 76 percent of the physicians surveyed said they would approve the use of marijuana to help ease the pain of a woman suffering from breast cancer.

Medical marijuana is legal in nearly half the states. The largest state in the Union, California, made it legal by popular vote nearly two decades ago. In the intervening years none of the "scare" issues raised during the referendum has manifest themselves. As the New York Times reported last week, "Warnings against partial legalization--of civil disorder, increased lawlessness and a drastic rise in other use--have proved unfounded."

William F. Buckley, the godfather of modern conservatism and the founder of the National Review argued for the legalization of medical marijuana (and marijuana in general for that matter). Another National Review icon, Richard Brookhiser, used marijuana (not legally at the time) when he battled cancer.

His testimony in favor of medical usage of marijuana before the House Judiciary Committee sums up my own thoughts: "My support for medical marijuana is not a contradiction of my principles, but an extension of them. I am for law and order. But crime has to be fought intelligently and the law disgraces itself when it harasses the sick. I am for traditional virtues, but carrying your beliefs to unjust ends is not moral, it is philistine. Most importantly, I believe in getting government off people's backs. We should include the backs of sick people trying to help themselves."

Guess we are both stuck agreeing with Sen. Leach on this one.

******************************************************************************************************************

YES

By Tony May

If you live in Pennsylvania don’t ask your doctor to prescribe marijuana for any medical purposes even though there is a growing body of research showing its usefulness as a pain reliever and even a tumor-inhibiting substance.  In fact, research published in Lancet , the journal of the British Medical Society, in 2006 premised that use of cannabis is less dangerous than tobacco, prescription drugs, and alcohol in terms of social harms, physical harm, and addiction.

The Pennsylvania General Assembly should follow the lead of 21 other states and approve the prescribing of marijuana for medical purposes.  While they are at it, they should give serious consideration to legalizing marijuana possession in small quantities of recreational use.  Pennsylvania needs to join other states in putting pressure on the federal government to rationalize its approach to marijuana – pretty much in the same way the federal government was persuaded that its 14-year experiment in attempting to ban the manufacture and consumption of beer, wine and whiskey was counter-productive.

The United States ended up repealing the 18 th Amendment (Prohibition) in 1933 pretty much because it was an abject failure.  Rather than leading to a decline in crime and alcohol abuse, it made lawbreakers out of millions of ordinary Americans and increased drunkenness.  It made organized crime a major growth industry.  Now, almost 80 years later, history has repeated.  Our jails are overcrowded, in no small part because of the trillion-dollar War on Drugs launched in the 1970s by Richard Nixon and carried on enthusiastically ever since by his successors in the oval office.

We’ve even been forced to ban the planting and harvesting of marijuana-related hemp plants for agricultural and industrial purposes, even though modern agri-science has created strains of hemp plants that are extremely low in cannabinoids. This in an era in which “natural fiber” is a major selling point for a host of consumer products.  Because we have been so afraid of marijuana in the U.S., we’ve blacklisted a plant which can produce a host of materials ranging from paper , textiles , clothing and biodegradable plastics to construction materials, body and cosmetic oils, health food and bio-fuels.  Hemp was once such a common agricultural product – used mainly for making rope and paper – that four Pennsylvania townships have Hempfield in their name.

Declaring a truce in the long war against marijuana will save taxpayer dollars at the federal, state and local levels – something that  should please taxpayers of every political inclination.  It should lead to a clearing of our jails and prisons of hundreds of not thousands of Pennsylvanians jailed for marijuana-related prosecutions.  Legalizing medical marijuana and decriminalizing the possession and use of marijuana for recreational purposes would lead to the structuring of a scheme of regulation and taxation, not unlike that used for alcoholic beverages.  In other words, it would create a new revenue source for the state.

Would there be or could there be a downside?  Certainly there is risk involved in the use of any product – but there is no indication that use of a regulated marijuana product would be less safe that use of illegal pot.  In fact, it should be safer, just like licensed alcohol slowly drove out the problems created by the consumption of bathtub gin and rotgut whiskeys produced in stills constructed of hazardous metals.

But, if you can accept the premise of British doctors that marijuana is less dangerous than alcohol, tobacco and prescription drug abuse – or, perhaps, no more dangerous – then the downside risk is minimal if non-existent.

SK3 Group Inc. (SKTO) Stock Research Links

SKTO Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Lilly's Retatrutide Outshines Ozempic in Key Diabetes Trial

Updated Category News Views 15

Lilly's Breakthrough in Diabetes Treatment Eli Lilly's retatrutide is stirring up the diabetes treatment waters. The latest Phase 3 comparison to Ozempic's top dose reveals some surprising results. I'm not one to toss out kudos lightly, but this could be a genuine game-changer if things hold steady. A1C Reductions: A Close Look at the Numbers We’re staring down the...

Continue Reading
Radiation Oncologist Dr. Pennock Honored: A Closer Look

Updated Category News Views 10

An Honor from The Inner Circle Sometimes, in a field stuffed with brilliant minds, a beacon stands out. That's Dr. Michael M. Pennock for you—a man who doesn’t just treat cancer patients but transforms their journeys with precision and empathy. Recognized as a Pinnacle Lifetime Member by The Inner Circle, Pennock’s dedication in the field of radiation oncology is...

Continue Reading
Infection Control Market Set for Explosive Growth by 2031

Updated Category News Views 35

Untangling the Surge in Infection Control Demand Lately, it's like every healthcare joint worldwide is scrambling for better infection control. We're talking about a market poised to jump from a whopping USD 58.5 billion in 2026 to USD 80.2 billion by 2031—a tidy 37% uptick. That change, brewing at a 6.5% CAGR, speaks volumes about where the industry's heading. What's...

Continue Reading
CashNetUSA Faces Class Action Over Exploitative Rates

Updated Category News Views 0

High-Risk Lending Meets Military Protections Ever seen a seemingly legal scheme that just leaves a sour taste? That's the vibe with CashNetUSA right now. They've landed in the hot seat over allegedly sky-high interest rates served up to folks who put on a uniform. We're talking about a proposed nationwide class action lawsuit accusing the lender of giving active-duty...

Continue Reading
Danobatgroup's New HQ in Shanghai Marks Strategic Shift

Updated Category News Views 83

Shanghai Beckons: A Game Changer for Danobatgroup One crisp morning in Shanghai marks a turning point for Danobatgroup. The Spanish heavy-hitter in machine tools has pinpointed the Shanghai Xinzhuang Industry Park in Minhang District for its Asia-Pacific headquarters. It ain't just another blip on the radar—this one's a calculated leap. Location, Location, Location...

Continue Reading
FluxCap Launches: Empowering Lawyers with Dynamic Tech

Updated Category News Views 54

A Fresh Force in Legal Tech: FluxCap Debuts Alright, strap in because the legal world just got itself a new team in the majors. FluxCap is breaking out into the open, promising to shake up how big, gnarly cases get tackled. These aren't just any cases; we're talking the kind that keep antitrust knuckles white and palms sweaty. It's like watching seasoned racecar drivers...

Continue Reading
Clip Expands Horizons with Pulpos Acquisition, New Board Member

Updated Category News Views 84

Clip's Strategic Move with Pulpos Clip just laid down a serious marker in the digital payment world by snagging Pulpos, a firm that’s got its claws deep into AI-driven business management software. This move isn't just some fancy headline. It's a real, grounded step in expanding Clip's ecosystem to bolster the backbone of Mexico's economy: small and medium-sized...

Continue Reading
Innovative Trial Targets Drug Resistance in Lung Cancer

Updated Category News Views 53

The Battle Against Drug Resistance Heats Up Folks, we're in a never-ending fight here against one of the toughest adversaries out there: lung cancer. And lemme tell ya, when drugs show resistance, it's like trying to punch a ghost. But there’s a fresh wind blowing, as Dr. Bobak Parang steps up to the plate with a $620K grant aimed squarely at tackling drug resistance in...

Continue Reading
Sony's LYTIA 720 Image Sensor: A Game Changer?

Updated Category News Views 88

Unpacking Sony's Latest Sensor: LYTIA 720 Tell me, when was the last time a tech drop made you shake your head in awe? Sony just pulled one of those moves with their latest toy, the LYTIA 720. We're talking a 50-effective megapixel CMOS image sensor crafted for mobile warriors, and it packs a punch that should have the competition looking over their shoulder. Dazzling...

Continue Reading
Civitas Boosts Orlando Luxury Hotel with $386M Loan

Updated Category News Views 0

Orlando Sets the Stage for Luxury Expansion Well, it seems Orlando's hospitality scene is about to get a significant bump. Civitas Capital Group just tossed a cool $386 million into the pot for the construction of a 700-key luxury hotel on the infamous International Drive. We're not talking about just another hotel here; this one's a real beast, a future InterContinental...

Continue Reading

Top 5 Most Recently Viewed Articles

Orbit Garant's First Quarter 2026 Performance Reviewed

Updated Category News Views 157

Overview of Financial Performance Orbit Garant Drilling Inc. (TSX: OGD) has released its financial results for the first quarter of fiscal 2026, ending on September 30, 2025. During this three-month period, the company recorded a revenue of $46.7 million, marking a 3.7% decline compared to $48.4 million during the same period last year. The revenue figures reflect a range...

Continue Reading
Celebrating Leadership Excellence at Coldwell Banker 2025

Updated Category News Views 250

Celebrating Achievements in Real Estate Leadership The Leadership Awards highlight the dedication of Coldwell Banker-affiliated real estate professionals who embody the core values of the organization. Recognizing Outstanding Contributions With a strong commitment to innovation and community service, Coldwell Banker Real Estate LLC, a subsidiary of Anywhere Real Estate...

Continue Reading
U.S. Drone Production Boost Promises Growth for Key Companies

Updated Category News Views 167

Major Shift in U.S. Drone Production Policies The recent announcement from the U.S. Defense Secretary has ignited excitement in the drone manufacturing industry. On a significant day, the Secretary unveiled plans to fast-track drone production through reforms aimed at simplifying procurement processes within the Pentagon. This bold move signifies a departure from previous...

Continue Reading
Acacia Research Set for Q3 2024 Financial Results Release

Updated Category News Views 96

Exciting Announcement from Acacia Research Acacia Research Corporation (NASDAQ: ACTG) is poised to share its financial outcomes for the third quarter of 2024. This revelation is set to occur before the market opens on a significant day in November. Businesses and investors alike are eager to gain insights into the company’s latest financial endeavors. What to Expect...

Continue Reading
Revolutionizing Grocery Shopping: Deliverect's New Retail Solution

Updated Category News Views 185

Revolutionizing Grocery Retail with Deliverect's Innovative Solution Deliverect, a leader in food technology software as a service (SaaS), has introduced Deliverect Retail to enhance the digital shopping experience for groceries. This important development allows grocery retailers to operate more effectively, which leads to better sales and improves customer satisfaction....

Continue Reading